vitamin K antagonist
Showing 1 - 25 of 8,812
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments
Completed
- Hemophilia A
- +2 more
- Vitamin K Antagonist - Drug
-
Brest, France
- +5 more
Apr 6, 2023
Antiphospholipid Syndrome, Arterial Thrombosis Trial in Buenos Aires, Córdoba, Hamilton (Dual antiplatelet therapy, Combined
Recruiting
- Antiphospholipid Syndrome
- Arterial Thrombosis
- Dual antiplatelet therapy
- +3 more
-
Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
- +2 more
Dec 12, 2022
AORTIC VALVE DISEASES, Thromboembolism Trial in Korea, Republic of (Rivaroxaban Oral Tablet, Vitamin K antagonist(warfarin))
Recruiting
- AORTIC VALVE DISEASES
- Thromboembolism
- Rivaroxaban Oral Tablet
- Vitamin K antagonist(warfarin)
-
Bucheon, Korea, Republic of
- +8 more
Oct 11, 2022
Non-vitamin K Antagonist Oral Anticoagulant Concentration and
Recruiting
- Atrial Fibrillation
- Data collection
-
Taipei, Please Select, Taiwan
- +1 more
Apr 17, 2022
Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)
Recruiting
- Ischemic Stroke
- Anticoagulant Adverse Reaction
- Dabigatran, rivaroxaban, apixaban, edoxaban
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 22, 2023
Intracerebral Hemorrhage Trial in Basel (Tranexamic acid, Saline 0.9%)
Completed
- Intracerebral Hemorrhage
- Tranexamic acid
- Saline 0.9%
-
Basel, SwitzerlandStroke Center, University Hospital Basel
Mar 22, 2022
Different Antithrombotic Therapy for Treatment of Ventricular
Recruiting
- Ventricular Thrombus
- non-vitamin K antagonist oral anticoagulants (NOACs)
- +3 more
-
Beijing, ChinaQing Yang
Jul 11, 2022
CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )
Active, not recruiting
- CTEPH
- Edoxaban
- +3 more
-
Fukuoka, JapanKyushu University Hospital
Aug 30, 2022
Real Life of New Oral Anticoagulants and Vitamin K Antagonists
Completed
- Atrial Fibrillation
- Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban
- Vitamin K antagonist: warfarin, fluindione, acenocoumarol
-
Paris, FranceAssistance Publique Hôpitaux de Paris
Mar 28, 2022
Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute
Recruiting
- Therapeutic Drug Monitoring
- Blood sampling to test drug level
-
Taipei, TaiwanNational Taiwan University Hospital
Mar 8, 2022
Nonvalvular Atrial Fibrillation Trial in Angers (Rivaroxaban 20 MG, Warfarin)
Recruiting
- Nonvalvular Atrial Fibrillation
- Rivaroxaban 20 MG
- Warfarin
-
Angers, FranceAngers University Hospital
Jul 25, 2022
NOACs Use in AF or VTE (SUNSHINE Registry)
Recruiting
- Atrial Fibrillation
- +2 more
- Patients with Atrial Fibrillation (AF) or venous thromboembolism (VTE)
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jun 6, 2022
Intra-cardiac Thrombus, STEMI, Heart Failure Trial in France, Réunion (Vitamin K antagonist, Direct oral anticoagulant)
Not yet recruiting
- Intra-cardiac Thrombus
- +2 more
- Vitamin K antagonist
- Direct oral anticoagulant
-
Angers, France
- +33 more
Apr 11, 2023
Incorporation of Protein Induced by Vitamin K Absence or
Completed
- Cancer of Liver
- No intervention
-
Hangzhou, Zhejiang, ChinaAffiliated Hangzhou First People's Hospital, Zhejiang University
Jun 8, 2023
Gather Information About Rivaroxaban in Sweden With Cancer Who
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +3 more
-
Multiple Locations, Many Locations, SwedenSwedish registries
Aug 18, 2022
Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,
Not yet recruiting
- Kawasaki Disease
- +4 more
- Rivaroxaban Oral Tablet or Suspension [Xarelto]
- +2 more
- (no location specified)
Dec 6, 2022
Anticoagulants in Patients With Venous Thromboembolism in Korea
Completed
- Venous Thromboembolism
- Parenteral anticoagulant
- +5 more
-
Seongnam-si, Korea, Republic of
- +1 more
May 20, 2022
Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin
Completed
- Venous Thromboembolism
- +3 more
- Rivaroxaban 20 MG [Xarelto]
- +2 more
-
Metepec, Estado De Mexico, MexicoInstituto Mexicano Del Seguro Social
Aug 24, 2022
Healthy Volunteers Trial in Groningen (Cofact)
Recruiting
- Healthy Volunteers
- Cofact
-
Groningen, NetherlandsPRA Health Sciences
Jan 12, 2022
Thromboembolic Events in Patients Receiving Kcentra® or Plasma
Completed
- Hemorrhage
- Kcentra®
- Plasma
-
Oakland, CaliforniaStudy Site
May 24, 2021
Learn More About Benefits and Side-effects of Drugs Rivaroxaban
Completed
- Atrial Fibrillation
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Many Sites, United KingdomMany facilities
Oct 27, 2021